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Abstract
Background: Understanding complex networks that modulate development in humans is hampered by genetic and
phenotypic heterogeneity within and between populations. Here we present a method that exploits natural variation in
highly diverse mouse genetic reference panels in which genetic and environmental factors can be tightly controlled. The
aim of our study is to test a cross-species genetic mapping strategy, which compares data of gene mapping in human
patients with functional data obtained by QTL mapping in recombinant inbred mouse strains in order to prioritize human
disease candidate genes.
Methodology: We exploit evolutionary conservation of developmental phenotypes to discover gene variants that influence
brain development in humans. We studied corpus callosum volume in a recombinant inbred mouse panel (C57BL/6J6DBA/
2J, BXD strains) using high-field strength MRI technology. We aligned mouse mapping results for this neuro-anatomical
phenotype with genetic data from patients with abnormal corpus callosum (ACC) development.
Principal Findings: From the 61 syndromes which involve an ACC, 51 human candidate genes have been identified.
Through interval mapping, we identified a single significant QTL on mouse chromosome 7 for corpus callosum volume with
a QTL peak located between 25.5 and 26.7 Mb. Comparing the genes in this mouse QTL region with those associated with
human syndromes (involving ACC) and those covered by copy number variations (CNV) yielded a single overlap, namely
HNRPU in humans and Hnrpul1 in mice. Further analysis of corpus callosum volume in BXD strains revealed that the corpus
callosum was significantly larger in BXD mice with a B genotype at the Hnrpul1 locus than in BXD mice with a D genotype at
Hnrpul1 (F=22.48, p,9.87*10
25).
Conclusion: This approach that exploits highly diverse mouse strains provides an efficient and effective translational bridge
to study the etiology of human developmental disorders, such as autism and schizophrenia.
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Introduction
The corpus callosum is the fibrous structure that connects both
hemispheres of the cortex in all placental mammals [1,2]. In
humans, this bridge is made up of more than 100 million axons of
neocortical neurons routing information between the left and the
right sides of the brain [3,4]. Improper development of the corpus
callosum may manifest itself in infancy by feeding problems, delays
in acquiring proper posture and the ability to walk, and
impairments in hand-eye coordination, speech, and visual and
auditory memory. In mild cases, symptoms such as repetitive
speech, social awkwardness, rigid thinking, poor problem solving,
and odd communication patterns may appear during elementary
school years. During puberty, children with an abnormal corpus
callosum (ACC) often fall behind in social understanding, social
communication, comprehension of non-literal language, problem
solving, executive skills, recognition of emotions, self-awareness,
and personal insight. Given the lack of specificity of symptoms of
an ACC, it is critical to properly diagnose an ACC, which may
either occur as an isolated clinical entity, as part of a syndrome (for
reviews see: [1,2,5,6]) or in association with complex phenotypes
such as autism or pontocerebellar hypoplasia [7,8]. Recent studies
have put forward potential candidate genetic mechanisms
underlying an ACC in humans, however, the question remains
how these genes contribute to abnormal development of this brain
region relevant to proper human functioning.
For example, developmental processes in mammals are
presumed to be controlled by complex genetic networks often
involving interaction of several loci and genes [9,10]. Unraveling
the myriad interactions within these networks is a major task in
clinical genetics, which faces the challenge of correctly interpreting
the phenotypic manifestations of perturbed development in
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developmental processes are among the evolutionary most
conserved, we hypothesize that the underlying genetic networks
and their interaction patterns are also highly conserved. Here, we
present an approach to interpret human genomic data relating to
perturbed developmental disease processes by making use of their
evolutionary conservation through natural genetic variation within
and across species. As a test case, we have analyzed a locus
involved in the development of the corpus callosum in the human
and the mouse brain.
Results
Prioritizing candidate loci and genes
Following a procedure used in a recent study of patients with
multiple congenital anomalies and mental retardation [11] we
used a disease cohort-specific compilation of genes involved in
syndromes involving an ACC to prioritize contributing loci, genes,
and biological processes. For the 61 autosomal recessive and
dominant, X-linked, metabolic, and chromosomal syndromes
which involve an ACC, 51 human candidate genes have been
identified (Table 1). Of these 19 (ARX, ATRX, DCX, EFNB1,
EP300, FCMD, FGFR1, FLNA, GLI3, HESX1, L1CAM, LARGE,
MID1, PAFAH1B1, PAX6, PTCH, RELN, WHSC1, and ZFHX1B)
fit into the Gene Ontology (GO) category of development
(GO:0007275; p value,0.0001 and Bayes Factor 15). The more
narrow category of neurogenesis (GO:0007399) includes 11 genes
(DCX, EFNB1, EP300, FCMD, FLNA, HESX1, L1CAM, LARGE,
PAFAH1B1, PAX6, and ZFHX1B;p ,0.0001 and Bayes Factor 16).
Both the p values (assuming a normal distribution of likelihoods)
and the Bayes factor, indicating the fold-likelihood that a model
fits the data vs. the neutral null-hypothesis, indicate a highly
significant association of these GO categories with an ACC [12].
Accordingly, an ACC may result from defective functioning of any
or several genes from a relatively limited set of genes required for
proper neurodevelopment.
From recent studies of structural genome rearrangements, 15
loci and consensus regions have emerged [13–25]. Results from
several studies converge onto regions 1q44, 6q27, and 15q21.2.
One could even interpret these studies as describing shared
consensus regions within bands 1q44, 6q27 and 15q21.2. The
studies of 1q44 deletions, however, have thus far resulted in three
mutually exclusive consensus regions [13–15,26,27]. The initially
proposed candidate gene AKT3 has subsequently been disputed
[14,15,28]. Submitting the candidate genes indicated by these
studies of structural genome rearrangements to an analysis of
shared Gene Ontologies did not yield a similar signature biological
process as found with syndromal genes (see above). This is not too
surprising since some of the CNVs are relatively large and often
contain ‘‘bystander’’ genes that are not likely to be involved in a
patient’s phenotype. To overcome this drawback, we sought a
novel approach by reasoning that the evolutionary conservation of
the development of the corpus callosum among mammals may
provide us with a clue.
Gene mapping with crosses of inbred mouse strains
Unbiased phenotype-driven approaches in mice may also
contribute to identification of genetic loci relevant to the
development of the corpus callosum in humans. Analyses of
mouse genetic reference populations (GRPs) allow for systematic
identification of quantitative trait loci (QTL) using controlled
genetic background and environmental conditions. For instance, a
recombinant inbred (RI) panel which is generated from a cross
between two inbred strains [29,30] (e.g., C57BL/6J6DBA/2J
(BXD)) [31]; followed by an F1 intercross and 20 generations of
inbreeding has proven to be a powerful instrument for studies of
complex genetic traits on the basis of natural variation [29–31].
Here, we focused our analysis on the corpus callosum volume
spanning a wide range (,8.5 to 17.6 mm
3) across individuals of
the BXD panel (with known genotypes). Through interval
mapping (using the online GeneNetwork system at www.genenet-
work.org) we identified a single significant QTL on mouse
chromosome 7 for corpus callosum volume with a QTL peak
located between approximately 25.5 and 26.7 Mb (Figure 1A).
The peak of the QTL-interval just reached genome-wide
significance level with a log of odds (LOD) score of 2.8
(permutation likelihood ratio statistic, or LRS, threshold is
computed of the genome-wide p value of 0.05 using 1000
permutations). This locus on chromosome 7 contains approxi-
mately 46 genes.
Comparing the genes in this QTL region with those associated
with syndromes involving an ACC (Table 1) and those covered by
CNVs yielded a single gene overlap, namely the HNRPU gene in
humans and its homolog Hnrpul1 in mice. Further analysis in BXD
strains revealed that the corpus callosum was significantly larger in
strains with a B genotype at the Hnrpul1 locus (15.5361.90 mm
3)
compared to strains with a D genotype (10.8562.65 mm
3)
(ANOVA analysis: F=22.48, p,9.87*10
25)). The gene encoding
HNRPU is located in the q44 region of human chromosome 1 and
is included in the hemizygous 1q44 losses of 32 out of the 41
published cases showing an ACC on MRI (Figure 1B). Taken
together, these suggest that humans and mice share a single locus
encompassing one gene that may control corpus callosum
development. Interestingly, the mouse locus also contains Zfp260
and Dmpk, two highly polymorphic genes associated with cis eQTL
in the neocortex (data not shown), suggesting that there may also
be a small complex of genes that modulate neocortical
development in close proximity on chromosome 7 in mouse.
Under the proviso that an ACC is the outcome of a perturbation
of neurodevelopment, it is conceivable that proper development of
the corpus callosum is controlled by a gene involved in the
processing of primary transcripts in the nucleus, which functions in
the mouse as a quantitative trait locus.
Discussion
Here we have presented an approach to identify genes that may
control brain development associated with human disease. For
this, we made use of evolutionary conservation of the development
of the corpus callosum in relation to natural genetic variation.
Thus, mapping of loci for an inherited defect in human patients is
complemented by experimental data generated by crossing inbred
mouse strains. Such crosses of inbred mice strains provide a tool
for ‘‘genetic experiments’’ to test such hypotheses and select
relevant human candidate genes from the many genes currently
associated with syndromes involving an ACC. We hypothesize that
comparing patterns of genetic control of conserved developmental
processes among animal species may be fruitful for other, not only
neurological, developmental processes. Very recent studies
indicated that cross-species genome comparisons in relation to
preserved phenotypes may also apply to other complex disorders,
such as hypertension [32] and psychiatric disorders [33], and thus
may open new roads for understanding disease etiology.
This conjecture prompts several ramifications. First, the
development of the corpus callosum may be under the control
of a transcriptional network composed of HNRPU and its putative
downstream targets. Second, hemizygous losses of HNRPU may
not be the sole genetic cause of an ACC. Several studies have
Interspecies Convergence Mapping of Disease Genes
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Syndrome Locus Gene OMIM Syndrome Locus Gene OMIM
Autosomal-dominant
Apert 10q26 FGFR2 101200 Lissencephaly 3 12q12-q14 TUBA1A 611603
Basal cell nevus 9q22.3 PTCH 109400 Rubinstein-Taybi 16p13.3 CREBBP 180849
22q13 EP300 180849
Greig cephalo-polysyndactyly 7p13 GLI3 175700 Septo-Optic dysplasia (SOD) 3p21.2-p21.1 HESX1 182230
Kallmann 2 8p11.2-p11.1 FGFR1 147950 Sotos 5q35 NSD1 117550
Autosomal-recessive
Acrocallosal 7p13 GLI3 200990 Lissencephaly 2 7q22 RELN 257320
Andermann 15q13-q14 SLC12A6 218000 Marden-Walker 248700
Aniridia type II 11p13 PAX6 106210 Meckel-Gruber 17q22-q23 249000
Coffin-Siris 7q32-q34 135900 Microcephalic
osteodysplastic primordial
dwarfism (MOPD) type 1
210710
Dincsoy 601016
Fryns 229850
Fukuyama congenital muscular
dystrophy
9q31 FCMD 253800 MOPD type 3 210730
Hydrolethalus 11q24.2 HYLS1 236680 Mowat-Wilson 2q22 ZFHX1B 235730
Joubert 9q34.3 213300 Muscle-eye-brain disease 1p34-p33 POMGNT1 253280
11p12-q13.3 608091 Neu-Laxova 256520
8q21.13-q22.1 TMEM67 610688 Septooptic dysplasia 3p21.2-p21.1 HESX1 182230
6q23.3 AHI1 608629 Toriello-Carey 217980
2q13 NPHP1 609583 Vici 242840
3q11.2 ARL13B 612291 Walker-Warburg 9q34.1 POMT1 607423
4p15.3 CC2D2A 612285 14q24.3 POMT2 607439
16q12,2 RPGRIP1L 611560 19q13.3 FKRP 606596
12q21.3 CEP290 610188 22q12.3-q13.1 LARGE 603590
Lowry-Wood 226960 9q31 FKTN 607440
Lyon 225740 Warburg-Micro 2q21.3 RAB3GAP 600118
X-linked
Aicardi Xp22 304050 X-linked lissencephaly Xq22.3-q23 DCX 300067
ATR-X Xq13 ATRX 301040 Lissencephaly X-linked 2 Xp22.13 ARX 300215
Aqueductal stenosis/ hydrocephalus
(MASA syndrome; X linked) or
Hydrocephalus due to congenital
stenosis of aqueduct of Sylvius
Xq28 L1CAM 307000 Lujan-Fryns Xq13 309520
Microphthalmia with
linear skin defects
Xp22.31 309801
Opitz Xp22 MID1 300000
Opitz-Kaveggia Xq13 MID12 305450
Oro-facial digital type 1 Xp22.3-p22.2 CXORF5 311200
Craniofrontonasal Xq12 EFNB1 304110 Periventricular heterotopia Xq28 300049
Lenz micropthalmia Xq27-q28 309800 Proud Xp22.13 ARX 300004
Metabolic disorders
Fumarase deficiency 1q42.1 FH 606812 Smith-Lemli-Opitz 11q12-q13 DHCR7 270400
Glycine encephalopathy 9p22 GCSP 606812
PDH deficiency Xp22 PDHA1 312170 Zellweger 6q23-q24 PEX3 214100
Chromosomal (contiguous gene and deletion) syndromes
ACC with ectodermal dysplasia
(hypohidrotic)
225040 Miller Dieker
Lissenecephaly
17p13.3 247200
Delleman syndrome
(Oculocerebrocutaneous)
164180 Ocular motor apraxia
(Cogan-syndrome)
2q13 257550
Interspecies Convergence Mapping of Disease Genes
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Lissencephaly type I 17p13.3 LIS1 607432 Opitz GBBB 22q11.2 145410
Lissencephaly type III 17p13 PAFAH1B1 601545 Wolf–Hirschhorn 4p16.3 WHSC1 194190
doi:10.1371/journal.pone.0018612.t001
Table 1. Cont.
Figure 1. Genetic mapping of corpus callosum volume in the BXD mouse genetic reference panel. Likelihood ratio (LRS; ordinate) of the
association or linkage between differences in corpus callosum volume and natural genetic variation as a function of position in the mouse genome
(chromosome number and coordinates in megabses given; abscissa). Note the single genome-wide significant peak in mouse chromosome 7 (A).
Overlapping deletions in genomic region 1q44 in patients with an ACC (B). Black bars and arrows indicate hemizygously deleted regions. Grey bars
and arrows indicate hemizygous deletions found in subject with a normal corpus callosum. Vertical lines indicate the region that is hemizygous in 32
out of 41 cases, and overlaps with the mouse QTL.
doi:10.1371/journal.pone.0018612.g001
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cause an ACC [14,15,34]. However, any mutation affecting
proper functioning of the HNRPU gene product and its interaction
with other proteins may lead to an ACC. These mutations are not
necessarily limited to the HNRPU gene product, but may include
genes encoding downstream targets. Such genes may either have
been identified in syndromes involving an ACC or may be covered
by the CNVs found in sporadic patients with an ACC, or have as
yet not been identified. This offers a potential explanation for the
phenotypic diversity of patients with hemizygous losses in 1q44. It
also suggests an explanation for the heterogeneity of loci and genes
potentially involving an ACC. Given the clinical importance of an
ACC, and the many ramifications of this hypothesis, functional
experimental tests appear worthwhile. Furthermore, this approach
of integrating mouse genetic mapping data of evolutionary
conserved phenotypes may also proof useful for a wide variety of
complex human diseases, such as congenital heart disease, eating
disorders, and autism spectrum disorders.
Materials and Methods
Prioritizing candidate loci and genes
To systematically determine genes or CNVs that were
specifically found among patients with an ACC, or in syndromes
involving an ACC, we analyzed our data using the Gene
Annotation Tool to Help Explain Relationships (GATHER)
developed by Chang and Nevins [12]. The algorithms embedded
herein allow to determine significance of association with regards
to shared biological processes (using Gene Ontology: http://www.
geneontology.org/GO.doc.shtml), chromosomal locations or bio-
chemical pathways (using KEGG: http://www.genome.jp/kegg/).
The algorithms generate p values (assuming a normal distribution
of likelihoods) and a Bayes factor, indicating the fold-likelihood
that a model fits the data vs. the neutral null-hypothesis, to
indicate significance of association of GO categories with an ACC
[12].
Gene mapping with crosses of inbred mouse strains
To study genetic factors that contribute to differences in brain
structure we focused on a subset of fully inbred BXD RI strains,
where each of the strains contains a unique genetic pattern of the
genomes from the maternal and paternal strains. Age-matched
pairs (male and female) of mice belonging to 11 inbred strains (56–
64 days of age) were obtained directly from the Jackson
Laboratory (www.jax.org): C57BL/6J (B6), DBA/2J (D2), and
the following nine BXD recombinant inbred strains—BXD1,
BXD6, BXD15, BXD16, BXD24, BXD28, BXD29, BXD34, and
BXD40. We intentionally studied age-matched male–female pairs
from different litters. To ensure that the low levels of within-strain
variance are not simply due to a common litter effects, we chose
that same strain mice coming from different litters. (This is
analogous to the situation of monozygotic human twins raised in
different environments.)
To study structural variation of the brain in this family of strains
we used high-resolution magnetic resonance microscopy (MRM)
imaging techniques [35] of actively stained brain specimens,
followed by semi-automated segmentation of the brain images
[36–39] into 33 major regions — gray matter nuclei, white matter
fibers, and ventricular space.
Imaging was performed at the Duke Center for In Vivo
Microscopy. All experiments were conducted in accordance with
NIH guidelines, using protocols approved by the Duke University
Institutional Animal Care and Use Review Committee under
IACUC protocol number A123-07-04. The Duke animal
program has AAALAC accreditation number 363, since 1976;
NIH/PHS assurance number A3195-01, current through 2013.
Mice were anesthetized with 100 mg/kg pentobarbital (i.p.) and
then fixed by transcardial perfusion, first with a flush of a mixture
of 0.9% saline and gadoteridol contrast agent —ProHance
(Bracco Diagnostics, Princeton, NJ) (10:1, v:v), followed by a
mixture of 10% formalin and ProHance (10:1, v:v). Whole heads
were stored overnight in formalin, and then trimmed to remove
the lower jaw and muscle. Brains were scanned within the cranial
vault to avoid distortions or damage to the tissue during excision
from the cranium. The fixed specimens were imaged using a 9.4
T (400 MHz) vertical bore Oxford magnet with a GE EXCITE
console (Epic 11.0). A 14-mm diameter solenoid RF coil was used
for the ex-vivo, in-situ mouse brains. We used a 3D spin warp
sequence with the readout gradient applied along the long
(anterior–posterior) axis of the brain. The multispectral data
consist of a T1- and a T2-weighted imaging protocols. The T1-
weighted sequence was acquired with an echo time (TE) of
5.1 ms, repetition time (TR) 50 ms, 62.5 kHz bandwidth, field of
view (FOV) of 11611622 mm. A T2 multiecho sequence was
acquired with a Carr Purcell Meiboom Gill sequence using the
same FOV and bandwidth, with TR of 400 ms and echo spacing
of 7 ms (16 echoes). To produce data heavily dependent on T2
differences the 16 echoes were MEFIC processed, i.e. Fourier
transformed along the echo time line [40]. Asymmetric sampling
of k-space with dynamic adjustment of receiver gain, and partial
zero filling of k-space were used to achieve an image matrix size
of 102465126512, resulting in an isotropic 21.5 mm resolution,
in 2 h 7 min for the T1-weighted dataset. A matrix of
51265126256 with isotropic resolution of 43 mm was generated
for the T2-weighted data with total acquisition time of 4 h,
20 min.
We used the T1-weighted images and an atlas of the C57BL/6
mouse brain [36] as a basis for an atlas based segmentation. The
T1 images were downsampled to 43 microns in order to decrease
memory and computational demands. IRTK [41] was used to
perform a suite of affine and nonrigid (free-form) registration
between the atlas and the query datasets. The atlas labels were
subjected to the same transformation that maximizes the
normalized mutual information among the atlas and query images
provided label sets for each query image. The resulting labels
where manually corrected where necessary, using both the T1 and
the T2 weighted scans, to improve the results based on local
alignment.
The volumes of the segmented brain regions were calculated
using MATLAB (MathWorks, Natick, MA). Strain averages for
volumes of 35 independent and compound regions were entered
into GeneNetwork (GN) (www.genenetwork.org). Exiting software
tools within GN, including web QTL [42] were used for mapping
of quantitative trait loci (QTLs) contributing to corpus callosum
volume. Since only two genotypes can be investigated in these
strains (B/B and D/D), all effects are analyzed under an additive
model.
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